City

Bethesda (1)

Hangzhou (1)

Roskilde (1)

Condition

Inflammatory Skin Disease (3)

Chronic Granulomatous Disease (1)

Fungal Infection (1)

Inflammatory Gastrointestinal Disease (1)

Inflammatory Lung Disease (1)

Yeast Infection Skin (1)

Overall Status

Enrolling by invitation (1)

Not yet recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (2)

phase 1/phase 2 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Zealand University Hospital (1)

Collaborator

Intervention

chlorpheniramine-codeine (1)

sample collection (swap or tape strip) (1)

xeljanz (tofacitinib) (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

inflammatory skin disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Granulomatous Disease, Inflammatory Gastrointestinal Disease, Inflammatory Skin Disease Trial run by the NIAID (XELJANZ

Enrolling by invitation

Chronic Granulomatous Disease
+3 more

XELJANZ (tofacitinib)

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 19, 2023

Fungal Infection, Inflammatory Skin Disease, Yeast Infection Skin Trial in Roskilde (sample collection (swap or tape strip))

Not yet recruiting

Fungal Infection
+2 more

sample collection (swap or tape strip)

Roskilde, Denmark

Zealand University Hospital Roskilde

Jul 13, 2021

Inflammatory Skin Disease Trial in Hangzhou (Chlorpheniramine-Codeine)

Unknown status

Inflammatory Skin Disease

Chlorpheniramine-Codeine

Hangzhou, Zhejiang, China

2 nd Affiliated Hospital, School of Medicine, Zhejiang Universit

Jun 16, 2021